XPO Inc, a transportation giant with a market capitalization of $17.3 billion, reported its fourth-quarter earnings for 2024, surpassing expectations with an adjusted earnings per share (EPS) of $0.89 ...

The S&P 500 Index ($SPX) (SPY) today is up +0.29%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.12%, and the Nasdaq ...

Bristol Myers Squibb reported strong fourth-quarter earnings but its outlook for 2025 failed to meet expectations.

HII's Q4 revenues total $3 billion, which miss the Zacks Consensus Estimate by 0.9%. The top line declines 5.4% year over ...

CEO Ashish Chand highlighted that Belden exceeded its guidance for Q4 2024, achieving $666 million in revenue and an EPS of $1.92. Revenue grew 21% year-over-year, while adjusted EBITDA margins ...

Kenvue posted mixed Q4 earnings, with in-line EPS but revenue below estimates, driven by challenges in its Skin Health and ...

Reports Q4 revenue $829.4M, consensus $827.43M. CEO Ivo Jurek commented, “In 2024, we generated a 180 basis point increase in our gross margin ...

Clinical research company IQVIA (NYSE: IQV) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 2.3% year on ...

ConocoPhillips (NYSE: COP) reported Q4 results, with $14.74B revenue and $1.98 EPS, surpassing expectations. Company also announced dividends and production targets for 2025.

Adjusted EBITDA of $996 M for the fourth quarter, $3,684 Mfor the full year;R&D Solutions quarterly bookings of over $2.5 billion, representing a book-to-bill ratio of 1.20x ;R&D Solutions contracted ...

Eli Lilly's Q4 revenue surged 45% to $13.53 billion, fueled by Mounjaro and Zepbound. 2025 guidance forecasts up to $61 billion in sales, driven by new drug launches.